Management of Obstructive Colon Tumors in Istanbul

NCT ID: NCT05424939

Last Updated: 2022-06-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-01

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the outcome of obstructive colon cancer surgery in terms of days-to-starting adjuvant therapy and quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colon Cancer Tumor Obstruction Emergencies Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Colectomy

Colon resection

Intervention Type PROCEDURE

Stoma procedures

Any type of colostomy or ileostomy with or without bowel resection

Intervention Type PROCEDURE

By-pass/laparotomy/laparoscopy/biopsy

Any palliative surgery without bowel resection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute intestinal obstruction due to colon cancer either preoperatively or intraoperatively detected
* Clinical findings of obstruction (Abdominal distention and pain, nausea or vomiting, and absence of bowel movements) confirmed by abdominal x-ray or CT

Exclusion Criteria

* Benign diseases
* Emergency surgery due to bleeding, perforation and other non-obstructive situations
* Recurrent colon tumors
* Rectal cancer
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul Medipol University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Osman Civil, MD

Role: STUDY_DIRECTOR

Medipol University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medipol University Bahcelievler Hospital

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Medipol Mega Hospital

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Naciye Cigdem Arslan, MD

Role: CONTACT

+90 531 389 09 75

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Osman Civil, MD

Role: primary

+905058334286

Mustafa Oncel, MD

Role: primary

+905324247750

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E-10840098-772.02-1214

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.